Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.7600 (2.5%) ($6.7600 - $6.7600) on Wed. Aug. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 49 | Latest Price | $6.7600(2.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -1.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(71%) ARKG(70%) ARKK(67%) IWO(65%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -2.035% in a week (0% probabilities). VIXM(-49%) VXX(-38%) UUP(-16%) TLT(-5%) SHY(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.92 | 5 Day Moving Average | $6.74(0.3%) | 10 Day Moving Average | $6.69(1.05%) | 20 Day Moving Average | $6.92(-2.31%) | To recent high | -23.1% | To recent low | 5.9% | Market Cap | $559m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |